Integer Holdings Co. (NYSE:ITGR) Shares Acquired by Charles Schwab Investment Management Inc.

Charles Schwab Investment Management Inc. raised its position in Integer Holdings Co. (NYSE:ITGR - Free Report) by 1.2% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 404,029 shares of the medical equipment provider's stock after buying an additional 4,946 shares during the period. Charles Schwab Investment Management Inc. owned about 1.20% of Integer worth $52,524,000 at the end of the most recent reporting period.

Several other large investors also recently bought and sold shares of ITGR. Blue Trust Inc. lifted its stake in shares of Integer by 460.4% in the second quarter. Blue Trust Inc. now owns 5,643 shares of the medical equipment provider's stock worth $658,000 after buying an additional 4,636 shares in the last quarter. Earnest Partners LLC boosted its holdings in shares of Integer by 3.2% during the 2nd quarter. Earnest Partners LLC now owns 1,208,319 shares of the medical equipment provider's stock worth $139,911,000 after purchasing an additional 37,340 shares during the last quarter. Great Lakes Advisors LLC grew its position in shares of Integer by 56.7% in the second quarter. Great Lakes Advisors LLC now owns 45,218 shares of the medical equipment provider's stock valued at $5,236,000 after purchasing an additional 16,355 shares in the last quarter. SG Americas Securities LLC acquired a new stake in shares of Integer in the third quarter valued at approximately $651,000. Finally, Wealth Enhancement Advisory Services LLC purchased a new position in Integer during the second quarter worth approximately $247,000. 99.29% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

ITGR has been the subject of a number of recent research reports. Citigroup raised their target price on Integer from $124.00 to $130.00 and gave the stock a "neutral" rating in a research note on Tuesday, October 1st. Truist Financial decreased their target price on shares of Integer from $150.00 to $147.00 and set a "buy" rating on the stock in a report on Friday, October 25th. Benchmark raised their price target on shares of Integer from $130.00 to $140.00 and gave the stock a "buy" rating in a report on Monday, October 21st. Piper Sandler reiterated an "overweight" rating and issued a $140.00 price objective (up from $125.00) on shares of Integer in a report on Friday, October 25th. Finally, Bank of America raised their target price on Integer from $135.00 to $145.00 and gave the stock a "buy" rating in a research note on Tuesday, October 1st. One analyst has rated the stock with a hold rating and seven have assigned a buy rating to the company's stock. According to data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $139.75.

Integer Stock Down 0.2 %

Integer stock traded down $0.30 during midday trading on Friday, reaching $140.50. The company's stock had a trading volume of 149,717 shares, compared to its average volume of 254,823. The company has a quick ratio of 2.09, a current ratio of 3.28 and a debt-to-equity ratio of 0.67. The company has a market cap of $4.71 billion, a P/E ratio of 43.36, a P/E/G ratio of 2.01 and a beta of 1.09. Integer Holdings Co. has a fifty-two week low of $84.75 and a fifty-two week high of $142.00. The business has a 50-day simple moving average of $131.38 and a 200-day simple moving average of $124.45.

Integer (NYSE:ITGR - Get Free Report) last issued its earnings results on Thursday, October 24th. The medical equipment provider reported $1.43 EPS for the quarter, topping the consensus estimate of $1.36 by $0.07. Integer had a net margin of 6.70% and a return on equity of 11.63%. The company had revenue of $431.42 million for the quarter, compared to analyst estimates of $440.59 million. During the same period in the previous year, the firm earned $1.27 EPS. The business's revenue was up 8.7% on a year-over-year basis. On average, research analysts expect that Integer Holdings Co. will post 5.33 earnings per share for the current fiscal year.

Integer Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.